Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Specimen Handling 456 Magnetic Resonance Spectroscopy 347 pembrolizumab 287 Biopsy 245 Carboplatin 228 Cisplatin 194 Cyclophosphamide 178 Paclitaxel 160 Nivolumab 153 Gemcitabine 147 Bevacizumab 126 Radiotherapy 124 Dexamethasone 110 Pemetrexed 101 fludarabine 96 Fluorouracil 95 atezolizumab 93 Radiation 92 Docetaxel 90 venetoclax 89 Doxorubicin 88 durvalumab 85 Oxaliplatin 85 Rituximab 84 Leucovorin 81 Capecitabine 76 Prednisone 73 Lenalidomide 70 X-Rays 69 Etoposide 67

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chemoradiotherapy, Adjuvant × 30 days × Clear all

NCT05667298 2026-05-11

OPERARADIO

University of Manitoba

Phase 1 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡